Patent holdings for IPC class A61K 31/485

Total number of patents in this class: 3163

10-year publication summary

406
449
441
368
337
341
310
255
206
69
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Antecip Bioventures II LLC
300
174
Purdue Pharma L.P.
519
138
Alkermes Pharma Ireland Limited
307
66
Purdue Pharmaceuticals L.P.
47
47
Euro-celtique S.A.
124
46
Indivior UK Limited
201
43
Nalpropion Pharmaceuticals LLC
72
42
Toray Industries, Inc.
6652
37
LTS Lohmann Therapie-Systeme AG
691
34
Rhodes Technologies
64
34
Ldn Pharma Limited
38
34
SpecGx LLC
197
33
Zevra Therapeutics, Inc.
85
30
Nektar Therapeutics
503
27
The Procter & Gamble Company
22178
25
Pharnext
106
25
Grünenthal GmbH
625
23
Ohemo Life Sciences Inc
23
22
Wyeth LLC
691
20
Mallinckrodt LLC
135
20
Other owners 2243